ARCHIVES

DCT board Okays Recompetition of Clinical Trials Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 42 | October 29, 1993

Download PDF Visit The Full Archive

Related Articles

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

In Brief: Cady New SSO President, Rush President Elect; Polockwich, Major Figure In Straus Case, Killed

June 17, 1988

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

Byrd Seeks Federal Tar-Nicotine Limit

October 22, 1976

Peter Boyle Elected IARC Director

May 23, 2003

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975